Haleon Us Holdings Company Profile
What is the competitive landscape for HALEON US HOLDINGS
HALEON US HOLDINGS has thirty-one approved drugs.
There are eight US patents protecting HALEON US HOLDINGS drugs.
Summary for Haleon Us Holdings
| US Patents: | 8 |
| Tradenames: | 28 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for Haleon Us Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | NICORETTE | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 022360-001 | May 18, 2009 | OTC | Yes | No | 8,940,772 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Haleon Us Holdings | NICORETTE | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 022360-001 | May 18, 2009 | OTC | Yes | No | 8,501,164 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 019771-001 | Sep 19, 1989 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | CHILDREN'S ADVIL | ibuprofen | SUSPENSION;ORAL | 019833-002 | Sep 19, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | FLONASE | fluticasone propionate | SPRAY, METERED;NASAL | 020121-001 | Oct 19, 1994 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 021374-001 | May 30, 2002 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Haleon Us Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | FLONASE SENSIMIST ALLERGY RELIEF | fluticasone furoate | SPRAY, METERED;NASAL | 022051-002 | Aug 2, 2016 | 6,858,596 | ⤷ Start Trial |
| Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | 5,972,916 | ⤷ Start Trial |
| Haleon Us Holdings | CHILDREN'S ADVIL-FLAVORED | ibuprofen | SUSPENSION;ORAL | 020589-002 | Nov 7, 1997 | 10,238,640 | ⤷ Start Trial |
| Haleon Us Holdings | NICORETTE | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 021330-001 | Oct 31, 2002 | 5,110,605 | ⤷ Start Trial |
| Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | 8,883,849 | ⤷ Start Trial |
| Haleon Us Holdings | ALLI | orlistat | CAPSULE;ORAL | 021887-001 | Feb 7, 2007 | 6,004,996 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HALEON US HOLDINGS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 200 mg/38 mg | ➤ Subscribe | 2016-02-16 |
| ➤ Subscribe | Gum | 2 mg | ➤ Subscribe | 2013-01-22 |
| ➤ Subscribe | Capsules | 200 mg/30 mg | ➤ Subscribe | 2004-12-27 |
| ➤ Subscribe | Capsules | 60 mg | ➤ Subscribe | 2010-09-08 |
| ➤ Subscribe | Gum | 4 mg | ➤ Subscribe | 2013-01-22 |
International Patents for Haleon Us Holdings Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1930054 | ⤷ Start Trial |
| Austria | E476260 | ⤷ Start Trial |
| South Africa | 200504908 | ⤷ Start Trial |
| South Africa | 200710905 | ⤷ Start Trial |
| New Zealand | 535873 | ⤷ Start Trial |
| China | 1901958 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Haleon Us Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2506844 | SPC/GB18/020 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: A PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCETPABLE SALT THEREOF (E.G. VILANTEROL TRIFENATATE), AND FLUTICASONE FUROATE; REGISTERED: UK EU/1/17/1236/001(NI) 20171117; UK EU/1/17/1236/002(NI) 20171117; UK EU/1/17/1236/003(NI) 20171117; UK PLGB 19494/0287 20171117 |
| 0129748 | SPC/GB98/044 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: ORLISTAT; REGISTERED: UK EU/1/98/071/001 19980729; UK EU/1/98/071/002 19980729; UK EU/1/98/071/003 19980729; UK EO/1/98/071/004 19980729; UK EU/1/98/071/005 19980729; UK EU/1/98/071/006 19980729 |
| 1519731 | 13C0067 | France | ⤷ Start Trial | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
| 2506844 | LUC00077 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
| 0428642 | 57/2007 | Austria | ⤷ Start Trial | PRODUCT NAME: DOCOSANOL; NAT. REGISTRATION NO/DATE: 1-27014 20070518; FIRST REGISTRATION: SE 18517 20031114 |
| 1305329 | SPC/GB08/026 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
